InvestorsHub Logo
Followers 281
Posts 25967
Boards Moderated 6
Alias Born 01/27/2009

Re: tripple7 post# 1377

Monday, 08/14/2017 10:51:36 PM

Monday, August 14, 2017 10:51:36 PM

Post# of 3176
They won't confirm it but in my opinion the three major customers are Medcomp, CR Bard, and Access Scientific. They want ASNB to stay in business.

"Management believes that certain arrangements entered into subsequent to June 30, 2017 with three of our significant customers which provide inventory purchase financing and long-term commitments for continued product purchase alleviate any substantial doubt as to our ability to meet our obligations for the next twelve months as of the date these financial statements are issued"

Medcomp and Access Scientific are private companies. Manta estimates revenues at Medcomp to be 50-100 million, 5.7 million at Access Scientific. My guess is Bard contributed most of the advance.

I was hopping that Access Scientific would have bought a lot of product. So far this year they have 2 new distribution agreements and 3 new products with more on the way. Existing products are FDA approved and have the potential to be high volume sellers. They'd have to have their products available for the distributors. But maybe the very high product sales a while back were to Access Scientific for future use and Access Scientific is still sitting on a large supply of ASNB products. If they have success with the introduction of the new products then they'll have to stock up again on ASNB's Chronoflex C. Next 10q is in mid-November. Not expecting any news from the company before then

My posts are my opinion. Do not be influenced by anything you read on any message board website unless you can confirm it.